AU2347501A - Trp-protein-related mtr1 protein and dna sequence coding therefor - Google Patents

Trp-protein-related mtr1 protein and dna sequence coding therefor

Info

Publication number
AU2347501A
AU2347501A AU23475/01A AU2347501A AU2347501A AU 2347501 A AU2347501 A AU 2347501A AU 23475/01 A AU23475/01 A AU 23475/01A AU 2347501 A AU2347501 A AU 2347501A AU 2347501 A AU2347501 A AU 2347501A
Authority
AU
Australia
Prior art keywords
protein
mtr1
trp
coding therefor
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23475/01A
Inventor
Jerry Pelletier
Dirk Prawitt
Bernhard Zabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johannes Gutenberg Universitaet Mainz
Original Assignee
JOHANNES GUTENBERG UNI
Johannes Gutenberg Universitaet Mainz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOHANNES GUTENBERG UNI, Johannes Gutenberg Universitaet Mainz filed Critical JOHANNES GUTENBERG UNI
Publication of AU2347501A publication Critical patent/AU2347501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention relates to the human and mouse MTR1 protein, having at least one biological activity of a TRP protein and/or related to the etiology of BWS and /or tumors associated with modifications 11p15.5, in addition to MTR1-related proteins and the sequences coding therefor. The invention also relates to antibodies binding MTR1 or related proteins, in addition to antisense RNAs or ribozymes directed against the expression of MTR1, and medicaments and diagnostic methods in which said compounds are used.
AU23475/01A 1999-11-04 2000-11-06 Trp-protein-related mtr1 protein and dna sequence coding therefor Abandoned AU2347501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953167 1999-11-04
DE19953167A DE19953167A1 (en) 1999-11-04 1999-11-04 Protein MTR1 related to TRP proteins and coding DNA sequence
PCT/DE2000/003876 WO2001032693A2 (en) 1999-11-04 2000-11-06 Trp-protein-related mtr1 protein and dna sequence coding therefor

Publications (1)

Publication Number Publication Date
AU2347501A true AU2347501A (en) 2001-05-14

Family

ID=7927945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23475/01A Abandoned AU2347501A (en) 1999-11-04 2000-11-06 Trp-protein-related mtr1 protein and dna sequence coding therefor

Country Status (5)

Country Link
EP (1) EP1237910B1 (en)
AT (1) ATE407944T1 (en)
AU (1) AU2347501A (en)
DE (2) DE19953167A1 (en)
WO (1) WO2001032693A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364867B2 (en) 2000-04-17 2008-04-29 The Mount Sinai School Of Medicine Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells
US20040219579A1 (en) * 2003-02-19 2004-11-04 Natasha Aziz Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
JP4594924B2 (en) 2003-02-21 2010-12-08 ザ クイーンズ メディカル センター TRPM5 modulator screening method
US7087394B2 (en) 2003-03-05 2006-08-08 Metabolex, Inc. Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP
US7875452B2 (en) * 2007-10-01 2011-01-25 Redpoint Bio Corporation Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500035A (en) * 1998-01-07 2002-01-08 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 36 human secreted proteins
CA2360396A1 (en) * 1998-12-30 2000-07-13 Andrew M. Scharenberg Characterization of a calcium channel family

Also Published As

Publication number Publication date
EP1237910B1 (en) 2008-09-10
EP1237910A2 (en) 2002-09-11
WO2001032693A2 (en) 2001-05-10
WO2001032693A3 (en) 2002-06-20
DE50015355D1 (en) 2008-10-23
DE19953167A1 (en) 2001-07-26
ATE407944T1 (en) 2008-09-15

Similar Documents

Publication Publication Date Title
WO1999033982A3 (en) Human genes and gene expression products i
WO2001012659A3 (en) Human dna sequences
TW428026B (en) Bifunctional protein, preparation and use
WO1999038972A9 (en) Human genes and gene expression products ii
ZA958444B (en) Biological active proteins
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
WO1999058675A3 (en) Human genes and gene expression products v
WO1999047674A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
DE69632536D1 (en) VACCINALS FOR THE RESPIRATORY SYNCYTIAL VIRUS WITH NUCLEIC ACIDS
WO1997033909A3 (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
WO1998050547A3 (en) Human toll-like receptor proteins, related reagents and methods
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
EP1005540A4 (en) Ikk-beta proteins, nucleic acids and methods
EP1553182A3 (en) Regulated genes and uses thereof
WO2001064877A3 (en) Human schizophrenia gene
NO985904L (en) TIE-2 receptor ligands (TIE-ligand-3, TIE-ligand-4), and use thereof
DE68911297D1 (en) HEPARIN-BINDING PROTEINS, CODING DNA, METHOD FOR THE PRODUCTION THEREOF AND THE THERAPEUTIC PREPARATIONS CONTAINING THEM.
WO1998011234A3 (en) Human protein kinases
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
WO1997009420A3 (en) Dna sequences coding for a human metalloproteinase and variants thereof
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
WO2001064876A3 (en) Human schizophrenia gene
WO1999018210A3 (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
WO2000018916A3 (en) Human genes and gene expression products
EP0780472A3 (en) Stress proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase